Altasciences Clinical Kansas Inc
CAGE Code: 6PS73
NCAGE Code: 6PS73
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 102335952
Summary
Altasciences Clinical Kansas Inc is an Active Commercial Supplier with the Cage Code 6PS73 and is tracked by Dun & Bradstreet under DUNS Number 102335952..
Address
10103 Metcalf Ave
Overland Park KS 66212-1758
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Wellsky Synergy Human & Social Sys-Tek, P.A American Info Systems Inc. Joseph A. Bellafiore, D.D.S., P.A. Mokan Labs, Llc Spencer Reed Group, Llc Akal It, Inc Nesha Enterprises Llc Main Commercial Solutions Llc Dames & Moore Inc Tekra Solutions Llc Compliance Label & Signs Llc Black & Veatch Special Projects Btw Home Maintenance Corp Hostetler And Associates Inc Arrowhead Contracting Holdco Llc Arrowhead Holding Company, Inc Achaibo Clinical Inc. University Of Kansas Hill's Pet Nutrition Sales Inc.
Frequently Asked Questions (FAQ) for CAGE 6PS73
- What is CAGE Code 6PS73?
- 6PS73 is the unique identifier used by NATO Organizations to reference the physical entity known as Altasciences Clinical Kansas Inc located at 10103 Metcalf Ave, Overland Park KS 66212-1758, United States.
- Who is CAGE Code 6PS73?
- 6PS73 refers to Altasciences Clinical Kansas Inc located at 10103 Metcalf Ave, Overland Park KS 66212-1758, United States.
- Where is CAGE Code 6PS73 Located?
- CAGE Code 6PS73 is located in Overland Park, KS, USA.
Contracting History for CAGE 6PS73 Most Recent 25 Records
- 75N95023F00001
- Pharmacokinetic And Pharmacodynamic Trials For Medication Development In Sud. To1 Phase 1 Cocaine Drug Interaction September 25, 2023 To March 24, 2025. N01da-23-893
- 22 Sep 2023
- Pharmacokinetic And Pharmacodynamic Trials For Medication Development In Sud. To1 Phase 1 Cocaine Drug Interaction September 25, 2023 To March 24, 2025. N01da-23-893
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,838,615.00
- Department Of Health And Human Services (Hhs)
- 75N95023D00019
- Pharmacokinetic And Pharmacodynamic Trials For Medication Development In Sud. September 25, 2023 To September 24, 2028. N01da-23-8935.
- 22 Sep 2023
- Pharmacokinetic And Pharmacodynamic Trials For Medication Development In Sud. September 25, 2023 To September 24, 2028. N01da-23-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75F40121C00199
- Ipp Modification
- 14 Jul 2023
- Ipp Modification
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $2,345,057.00
- Department Of Health And Human Services (Hhs)
- 75F40121C00199
- Dose-Finding Study Of Kratom Alkaloids Pilot
- 30 Sep 2021
- Dose-Finding Study Of Kratom Alkaloids Pilot
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $2,345,057.00
- Department Of Health And Human Services (Hhs)
- 75F40121C00199
- Eo14042-Dose Finding Study Of Kratom Alkaloids Pilot
- 16 Dec 2021
- Eo14042-Dose Finding Study Of Kratom Alkaloids Pilot
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $2,345,057.00
- Department Of Health And Human Services (Hhs)
- 75F40121C00199
- Eo14042-Dose Finding Study Of Kratom Alkaloids Pilot
- 21 Sep 2022
- Eo14042-Dose Finding Study Of Kratom Alkaloids Pilot
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $2,345,057.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Ordering Period: 9/20/2017-9/19/2022. N01da-17-8935.
- 23 Mar 2022
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Ordering Period: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Igf::Ot::Igf: Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- 20 Sep 2017
- Igf::Ot::Igf: Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- 17 Mar 2020
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- 18 Mar 2021
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Task Order No. 2. Phase 1 Study Of Cbd-Morphine Drug-Drug Interaction
- 14 Sep 2022
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Task Order No. 2. Phase 1 Study Of Cbd-Morphine Drug-Drug Interaction
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- 19 Sep 2019
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- 22 Sep 2020
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Pop: 9/20/2017-9/19/2022. N01da-17-8935.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Task Order No. 2. Phase 1 Study Of Cbd-Morphine Drug-Drug Interaction
- 25 May 2023
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. Task Order No. 2. Phase 1 Study Of Cbd-Morphine Drug-Drug Interaction
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)
- HHSN271201700056C
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. September 20, 2017 Through September 19, 2022
- 19 May 2023
- Pharmacokinetic And Pharmacodynamic Studies For Medications Development. September 20, 2017 Through September 19, 2022
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $3,416,384.00
- Department Of Health And Human Services (Hhs)